Featured research and insights
PublicationJune 29, 2023Over 80% of patients received their on-time second dose of mRNA-1273 vaccine per CDC recommendations. Patient demographics and community characteristics were associated with vaccine receipt and series completion.
PosterMay 10, 2023
Oral Oncology Proportion of Days Covered (PDC) Associations on Medical Costs and Hospitalization in Medicare MarketScan DataPresents results from a study validating use of an adherence metric for oral antineoplastic medications utilized by cancer patients and outcomes of total medical costs, hospitalizations and length of stay.
PosterMay 07, 2023
Medical costs, hospitalizations, and length of stay associated with discontinuations in cycled oral antineoplastics among Medicare-eligible oncology patientsMarketScan Medicare study sample demonstrated that medication adherence (fewer gaps in medicaton coverage) among patients on cycled oral antineoplastics can lead to lower medical costs, fewer hospitlization events and shorter lenght of stay as compared to lower adherence levels.